Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis
Status:
Terminated
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effectiveness of four dosing regimens of
fostamatinib compared to placebo, in patients with rheumatoid arthritis (RA) who are taking
methotrexate but not responding. The study will last for 12 weeks.